gms | German Medical Science

66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Friendship Meeting mit der Italienischen Gesellschaft für Neurochirurgie (SINch)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

7. - 10. Juni 2015, Karlsruhe

Vorträge Dienstag, 09. Juni 2015
DI.11 Freie Themen 7: Gliome Biomarker

Meeting Abstract (DI.11.01)

Textural features of high-grade glioma in pretherapeutic [18F]-FET-PET are correlated with tumor grade and survival

Pyka T, Gempt J, Ringel F, Wester HJ, Schwaiger M, Förster S
[Volltext]
Meeting Abstract (DI.11.02)

ALDH1A1 expression level as prognostic factor for survival of glioblastoma patients

Ringel F, Gempt J, Erlmeier F, Schneider F, Meyer B, Studiengruppe JSu
[Volltext]
Meeting Abstract (DI.11.03)

ALDH1A1 expression increases in recurrent glioblastoma patients and predicts a chemoresistant phenotype

Schneider F, Baur S, Schlegel J, Meyer B, Ringel F
[Volltext]
Meeting Abstract (DI.11.04)

OLIG2 is an independent prognostic immunohistochemical marker in glioblastoma

Behling F, Barrantes-Freer A, Horowski A, Hartmann C, Stockhammer F, Stadelmann C
[Volltext]
Meeting Abstract (DI.11.05)

Importance of biomarkers in glioblastoma patients receiving local BCNU wafer chemotherapy

Engelhardt J, Ketter R, Oertel J, Tschan C, Kammers K, Urbschat S
[Volltext]
Meeting Abstract (DI.11.06)

Association of molecular markers with tumor location and subventricular zone involvement in malignant glioma

Ahmadipour Y, Müller O, Schlamann M, Yuan Z, Sure U, Hindy NE
[Volltext]
Meeting Abstract (DI.11.07)

Epithelial membrane protein 3 expression is a strong prognostic marker in anaplastic astrocytomas

Stockhammer F, Christians A, Horowski A, Pusch S, Deimling Av, Hartmann C
[Volltext]
Meeting Abstract (DI.11.08)

Correlation of 5-ALA induced fluorescence with contrast enhancement on MRI, pre-operative FET-PET and tumor molecular factors in grade II and III astrocytomas

Jaber M, Ewelt C, Warneke N, Holling M, Hasselblatt M, Zoubi T, Stummer W
[Volltext]